Product Pipeline

OraCAb

OraCAb is an orally administered immunotherapeutic product containing ovine polyclonal antibodies directed against recombinant fragments of Toxin A and Toxin B for the treatment of mild to moderate severity primary and recurrent Clostridium difficile infections (“CDI”).